Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Immunohematology Industry?

The size of the immunohematology market has consistently expanded in the past few years. The market value is forecasted to surge from $2.46 billion in 2024 to $2.55 billion in 2025, representing a compound annual growth rate (CAGR) of 3.6%. The positive growth observed in the historical period is linked to developments in blood transfusion technology, the incidence of blood-related disorders, the broadening scope of blood banks, governmental initiatives promoting blood safety, a rise in surgical procedures, and an increased understanding of risks associated with transfusion.

The market for immunohematology is projected to exhibit robust growth in the coming years. The market’s size is expected to expand to “$3.17 billion by 2029 with a compound annual growth rate (CAGR) of 5.7%. The predicted growth during the forecast period is due to factors such as the growing need for point-of-care testing, the introduction of new blood products, enhancement in healthcare infrastructure, blood compatibility genetic testing, and regulatory backing for blood safety. Key trends during the forecast period will include automated and high-output systems, modern blood typing techniques, methods for antibody detection, patient blood management initiatives, and the application of artificial intelligence in analysis, as well as the integration of telemedicine.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp

#Which Factors Are Currently Driving The Growth Of The Immunohematology Market?

Increasing incidences of hematological disorders are anticipated to fuel the expansion of the immunohematology market in the future. Hematological disorders represent a wide array of conditions impacting the blood and its components, such as red cells, white cells, platelets, and plasma. Immunohematology plays a crucial role in carrying out secure and effective blood transfusions, as it helps avert transfusion reactions instigated by incompatible blood types or the existence of antibodies in the recipient’s blood. Techniques used in immunohematology are also utilized to diagnose and treat diseases linked to the immune system which could influence the hematological system. For example, according to Cancer Research UK, a research organization based in the UK, it’s expected that the average number of new leukemia cases arising from hematological disorders in the UK will rise from approximately 12,400 cases in 2023-2025 to roughly 14,500 cases in 2038-2040. Therefore, the increasing incidence rate of hematological disorders is propelling the expansion of the immunohematology market.

The immunohematology market covered in this report is segmented –

1) By Product: Analyzers And Systems, Reagents

2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)

3) By Disease: Blood-Related Diseases, HIV, Hepatitis

4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology

5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes

Subsegments:

1) By Analyzers And Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems

2) By Reagents: Blood Grouping Reagents, Antisera, Control Serum

What Long-Term Trends Are Likely To Affect The Immunohematology Market?

Many of the leading players in the immunohematology market are zeroing in on the creation of cutting-edge diagnostic tools, such as soluble recombinant proteins, which are geared towards offsetting the disruptive effects of daratumumab, a cancer treatment strategy. Soluble recombinant proteins, generated through the application of recombinant DNA methodology, hold their structures and functionality in a soluble form in host cells or solutions, making them beneficial for therapeutic and research purposes. For illustration, Grifols, S.A., a pharmaceutical entity based in Spain, introduced Grifols sCD38, a novel soluble recombinant protein-based solution in November 2023. Constructed to manage the disruptions daratumumab causes on important transfusion compatibility tests, Grifols’sCD38 is a pioneering solution that stops daratumumab from sticking to CD38 proteins on red blood cells, guaranteeing precise pre-transfusion test outcomes. Tailored explicitly for multiple myeloma patients, this solution boosts transfusion protocols and lessens the chances of delay in administering urgent transfusions, by ensuring a more streamlined procedure for crossmatching, identification, and screening.

Who Are The Main Participants Shaping The Immunohematology Market Landscape?

Major companies operating in the immunohematology market include Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Which Region Currently Holds The Largest Share In The Immunohematology Market?

North America was the largest region in the immunohematology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10295&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model